Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Operating Leases (2019 - 2025)

U S Physical Therapy's Operating Leases history spans 5 years, with the latest figure at $76.9 million for Q3 2023.

  • For Q3 2023, Operating Leases changed 0.03% year-over-year to $76.9 million; the TTM value through Sep 2023 reached $76.9 million, changed 0.03%, while the annual FY2022 figure was $77.9 million, 5.05% up from the prior year.
  • Operating Leases for Q3 2023 was $76.9 million at U S Physical Therapy, down from $78.9 million in the prior quarter.
  • Across five years, Operating Leases topped out at $78.9 million in Q2 2023 and bottomed at $55.8 million in Q1 2019.
  • The 5-year median for Operating Leases is $66.9 million (2021), against an average of $67.8 million.
  • The largest YoY upside for Operating Leases was 19.68% in 2021 against a maximum downside of 0.81% in 2021.
  • A 5-year view of Operating Leases shows it stood at $60.3 million in 2019, then increased by 2.87% to $62.0 million in 2020, then rose by 19.68% to $74.2 million in 2021, then grew by 5.05% to $77.9 million in 2022, then decreased by 1.35% to $76.9 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Operating Leases are $76.9 million (Q3 2023), $78.9 million (Q2 2023), and $75.5 million (Q1 2023).